Centiva Capital’s Wave Life Sciences WVE Stock Holding History

Centiva Capital’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11,871	Closed	-$67K	–	1654
2021 Q1	$67K	Buy	+11,871	New	+$114K	﹤0.01%	1079

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

GSK plc London $602M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Centiva Capital's WVE Position: Q2 2021 in Review

Centiva Capital sold out of Wave Life Sciences (WVE) in Q2 2021, closing a stake of 11,871 shares — an estimated $67K sold.

Centiva Capital first reported a position in WVE in Q1 2021 and held it in 1 quarter. The position peaked at $67K in Q1 2021. 87 funds tracked by Wall St. Rank hold WVE as of Q2 2021.

Centiva Capital reported no remaining Wave Life Sciences position as of Q2 2021 after selling out during the quarter.
Centiva Capital sold 11,871 Wave Life Sciences shares in Q2 2021, an estimated $67K.
Centiva Capital first reported a position in Wave Life Sciences in Q1 2021 and held it in 1 quarter.
Centiva Capital's Wave Life Sciences position peaked at $67K in Q1 2021.
87 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2021.

Based on Centiva Capital's 13F filing for Q2 2021, filed 16 Aug 2021.